Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
Go back to Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 145.57 -3.3 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.87 | 52 Week High | $0.52 | |||
| Open | $153.62 | 52 Week Low | $0.08 | |||
| Day High | $154.69 | P/E | N/A | |||
| Day Low | $141.52 | EPS | $-3.80 | |||
| Volume | 10,954,603 | |||||
